Estrigenix
ESTRIGENIX THERAPEUTICS, INC.
Next-generation therapeutics Pioneering therapies to improve women’s health Using applied and original estrogen-based research, our targeted chemistry aims to drastically reduce the mental and physical effects of menopause. Next-generation therapeutics Leading the way in developing improved therapeu
estrigenix.com · Wauwatosa, WI
Funding event
The round itself, as filedInferred stagePre-seed
Sold of offered$1.0M of $2.0M
Filed2026-07-27
Days since filing69
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-07-17
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Daniel SemExecutive Officer · Director
- William DonaldsonExecutive Officer · Director
- Karyn FrickExecutive Officer
- Patricia SchellerDirector
- Victoria ZellmerExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged50% sold2.6 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-240
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.